1 art rate slowing (bradycardia), syncope, or "lightheadedness".

2 -old man presented with a 6-month history of lightheadedness and intermittent balance and coordinatio

3 ovement in standing systolic BP, symptoms of lightheadedness, and a global symptom relief score (by t

4 t in the placebo group (headache, dizziness, lightheadedness, and chronic abdominal pain).

5 rter R-R intervals and more symptoms such as lightheadedness, despite similar levels of blood pressur

6 syndrome (32%-40%), pica (40%-50%), dyspnea, lightheadedness, exercise intolerance, and worsening hea

7 Persistent symptoms (eg, heart palpitations, lightheadedness, fatigue) despite resolution of acute CO

8 c intolerance is a syndrome characterized by lightheadedness, fatigue, altered mentation, and syncope

9 ects were relatively mild and included rash, lightheadedness, fatigue, and musculoskeletal pain.

10 c orthostatic intolerance report symptoms of lightheadedness, fatigue, and nausea accompanied by an e

11 logical (anxiety and sadness), neurological (lightheadedness, headache and numbness), cardiopulmonary

12 -old man presented with a 6-month history of lightheadedness, intermittent balance, and coordination

13 ly if a therapy is delivered or a feeling of lightheadedness is experienced.

14  commonly fever (n = 6), nausea (n = 5), and lightheadedness (n = 3).CONCLUSIONSAmong high-risk patie

15 r cognitive impairment, but without postural lightheadedness or near syncope.

16    Fifty-one cases (48%) included dizziness, lightheadedness, or a feeling of disequilibrium as the i

17 ated with reproducible symptoms of weakness, lightheadedness, or syncope.

18 nd transient, consisting mainly of sedation, lightheadedness, tachycardia, and hypotension; however,

19 dose-limiting toxicity of reversible grade 3 lightheadedness was observed.

20                                              Lightheadedness was the most common (97.6%) symptom and